These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6851057)

  • 1. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS
    Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
    Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.